Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease
- Seunghwan Shim
- , Da Un Jeong
- , Hyemi Kim
- , Chae Yun Kim
- , Hyejun Park
- , Yinglan Jin
- , Kyung Min Kim
- , Hwa Jeong Lee
- , Dong Hwan Kim
- , Yun Soo Bae
- , Yongseok Choi
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations